Lalo Flores is the founder of Century Therapeutics. Century Therapeutics has raised $160M in total funding. Latest round: Series C.
Lalo Flores is the Chief Executive Officer at Century Therapeutics, a company focused on developing induced pluripotent stem cell (iPSC)-derived cell therapies for immuno-oncology. Century Therapeutics recently completed a $160 million Series C financing round, led by Casdin Capital. The company aims to advance its pre-clinical pipeline of iPSC-derived CAR-iT and CAR-iNK cell products to treat hematologic and solid tumor cancers, with clinical testing of its first products anticipated in 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library